An increase in sedentary time from childhood is associated with a significant increase in blood insulin concentration, a new study shows.
Enhertu wins two FDA breakthrough therapy designations – Pharmaceutical Technology
The ADC is already approved in different settings for patients with breast cancer, non-small cell lung cancer and gastroesophageal junction adenocarcinoma. Image credit: Shutterstock/Christoph Burgstedt.